Expression of SGTA correlates with prognosis and tumor cell proliferation in human hepatocellular carcinoma

Pathology and Oncology Research

Volumn 20, Issue 1, 2014, Pages 51-60

  Lu, Cuihua ^a   Liu, Guoliang ^a   Cui, Xiaopeng ^a   Zhang, Jing ^a   Wei, Lixian ^a   Wang, Yingying ^a   Yang, Xiaojing ^a   Liu, Yanhua ^a   Cong, Xia ^a   Lv, Liting ^a   Ni, Runzhou ^a   Huang, Xiaodong ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Cell cycle; Hepatocellular carcinoma; Prognosis; Proliferation; Small glutamine rich TPR containing protein A (SGTA)

Indexed keywords

CYCLIN A; CYCLIN B; SMALL GLUTAMINE RICH TETRATRICOPEPTIDE REPEAT CONTAINING PROTEIN ALPHA; SMALL INTERFERING RNA; TETRATRICOPEPTIDE REPEAT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL CYCLE ARREST; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PREDICTIVE VALUE; PROTEIN DEPLETION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RNA INTERFERENCE; TUMOR CELL; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84896028915     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9657-6     Document Type: Article

References (29)

1. Zhou P, Wu LL, Wu KM et al (2012) Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinoma. Pathol Oncol Res 19(2):303-9
2. Xia LM, Huang WJ, Tian DA et al (2012) Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Hepatology 57(2):610-24
3. Guo XD, Xiong L, Zou L, Zhao JM (2012) Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma. Pathol Oncol Res 18(3):635-640
4. Yang H, Xiong FX, Lin M, Yang Y, Nie X, Zhou RL (2010) LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol 136(2):275-281
5. Zhao ZK, Dong P, Gu J, et al (2012) Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma. Tumour Biol 34(1):173-80
6. Callahan MA, Handley MA, Lee YH, Talbot KJ, Harper JW, Panganiban AT (1998) Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J Virol 72(10):8461 (Pubitemid 28421860)
7. Cziepluch C, Kordes E, Poirey R, Grewenig A, Rommelaere J, Jauniaux JC (1998) Identification of a novel cellular TPR-containing protein, SGT, that interacts with the nonstructural protein NS1 of parvovirus H-1. J Virol 72(5):4149-4156 (Pubitemid 28188720)
8. Kordes E, Savelyeva L, Schwab M, Rommelarere J, Jauniaux JC, Cziepluch C (1998) Isolation and characterization of human SGT and identification of homologues in Saccharomyces cerevisiae and Caenorhabditis elegans. Genomics 52(1):90-94 (Pubitemid 28452174)
9. Wang HZ, Shen HL, Wang YL et al (2005) Overexpression of small glutamine-rich TPR-containing protein promotes apoptosis in 7721 cells. FEBS Lett 579(5):1279-1284
10. Buchanan GB, Ricciardelli C, Jonathan M et al (2007) Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha. Cancer Res 67(20):10087-10096 (Pubitemid 47621260)
11. Moritz A, Li Y, Guo AL et al (2010) Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci Signal 3(136):ra64
12. Mochida S, Hunt T (2012) Protein phosphatases and their regulation in the control of mitosis. EMBO Rep 13(3):197-203
13. Winnefeld M, Rommelaere J, Cziepluch C (2004) The human small glutamine-rich TPR-containing protein is required for progress through cell division. Exp Cell Res 293(1):43-57 (Pubitemid 38064413)
14. Winnefeld M, Grewenig A, Schnölzer M et al (2006) Human SGT interacts with Bag-6/Bat-3/Scythe and cells with reduced levels of either protein display persistence of few misaligned chromosomes and mitotic arrest. Exp Cell Res 312(13):2500-2514 (Pubitemid 44055930)
15. Chan KS, Koh CG, Li HY (2012) Mitosis-targeted anti-cancer therapies: where they stand. Cell Death Dis 3:e411
16. He J, Wu J, Xu N et al (2012) MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genes. Nucleic Acids Res 41(1):498-508
17. Lu MD, Ma JB, Xue WQ et al (2009) The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma. Pathol Oncol Res 15(4):679-687
18. Ke Q, Ji JL, Cheng C et al (2009) Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma. Exp Mol Pathol 87(3):167-172
19. Wang YC, Liu F, Mao F et al (2013) Interaction with CCNH/CDK7 stabilizes CtBP2 and promotes cancer cell migration. J Biol Chem 288(13):9028-9034
20. Deng Q, Wang Q, Zong WY et al (2010) E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation. Cancer Res 70(2):782-791
21. Smith A, Simanski S, Fallahi M, Ayad NG (2007) Redundant ubiquitin ligase activities regulate wee1 degradation and mitotic entry. Cell Cycle 6(22):2795-2799 (Pubitemid 350277172)
22. McFarlane C, Kelvin AA, de la Vega M et al (2010) The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. Cancer Res 70(8):3329-3339
23. Uchida F, Uzawa K, Kasamatsu A et al (2012) Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest. BMC Cancer 12:321
24. Hur W, Rhim H, Jung CK et al (2010) SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. Carcinogenesis 31(7):1298-1307
25. Miyai K, Yamamoto S, Iwaya K et al (2012) Altered expression of p27(Kip1) -interacting cell-cycle regulators in the adult testicular germ cell tumors: potential role in tumor development and histological progression. APMIS 120(11):890-900
26. Demonacos C, Krstic-Demonacos M, La Thangue NB et al (2001) A TPR motif cofactor contributes to p300 activity in the p53 response. Mol Cell 8(1):71-84 (Pubitemid 32772906)
27. Xiang SL, Kumano T, Iwasaki SI, Sun X, Yoshioka K, Yamamoto KC (2001) The J domain of Tpr2 regulates its interaction with the proapoptotic and cell-cycle checkpoint protein, Rad9. Biochem Biophys Res Commun 287(4):932-940 (Pubitemid 32953566)
28. Imai Y, Soda M, Hatakeyama S et al (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell 10(1):55-67 (Pubitemid 34876562)
29. Dai Q, Zhang C, Wu Y et al (2003) CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J 22(20):5446-5458 (Pubitemid 37279954)